Recent insider trading activity from Garren Hideki, including buys and sells reported to the SEC.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 27, 2024 | PROTHENA CORP PUBLIC LTD CO | $PRTA | Garren Hideki | Chief Medical Officer | A | Stock Option (Right to Buy) | 85000 | $0.00 | 85,000.0000 | 53,216,000 | 9999.99% | 0.16% |
| Jan. 1, 2024 | Coya Therapeutics, Inc. | $COYA | Garren Hideki | Director | A | Stock Option (right to buy) | 5000 | $0.00 | 5,000.0000 | 0 | 9999.99% | 0.00% |